Home
Mail
Search
News
Finance
Sport
TV
Lifestyle
Entertainment
Mobile
Horoscopes
More
Yahoo
Mail
Watchlists
My Portfolios
Market Data
Latest News
Industries
Personal Finance
Currency Convertor
Video
New Zealand markets close in 5 hours 17 minutes
NZX 50
11,756.76
-44.02
(-0.37%)
NZD/USD
0.5998
-0.0008
(-0.13%)
ALL ORDS
8,065.50
+113.20
(+1.42%)
OIL
78.32
-0.06
(-0.08%)
GOLD
2,323.60
-0.60
(-0.03%)
Infinity Pharmaceuticals, Inc. (I3F.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.0171
0.0000
(0.00%)
At close: 08:36AM CEST
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
Currency in USD.
All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
2,569
2,593
1,858
1,719
Cost of revenue
1,549
1,563
1,120
1,037
Gross profit
1,020
1,030
738
682
Operating expenses
Research development
27,076
32,411
31,647
26,761
Selling general and administrative
15,990
13,463
14,174
12,418
Total operating expenses
43,066
45,874
45,821
39,179
Operating income or loss
-42,046
-44,844
-45,083
-38,497
Interest expense
180
180
180
2,445
Total other income/expenses net
1,278
655
1
450
Income before tax
-40,948
-44,369
-45,262
-40,492
Income tax expense
-
-
-
0
Income from continuing operations
-40,948
-44,369
-45,262
-40,492
Net income
-40,948
-44,369
-45,262
-40,492
Net income available to common shareholders
-40,948
-44,369
-45,262
-40,492
Basic EPS
-
-0.50
-0.53
-0.68
Diluted EPS
-
-0.50
-0.53
-0.68
Basic average shares
-
89,248
85,597
59,858
Diluted average shares
-
89,248
85,597
59,858
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.